Cargando…

Options for intravenous iron supplementation in hemodialysis patients

Detalles Bibliográficos
Autores principales:	Kong, Ji Yoon, Hwang, Hyeon Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Nephrology 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530365/ https://www.ncbi.nlm.nih.gov/pubmed/32938819 http://dx.doi.org/10.23876/j.krcp.20.140

Ejemplares similares

Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients
por: Kshirsagar, Abhijit V., et al.
Publicado: (2013)

Vitamin C and functional iron deficiency anemia in hemodialysis()
por: Kim, Yong-Lim
Publicado: (2012)

Intravenous iron supplementation does not increase infectious disease risk in hemodialysis patients: a nationwide cohort-based case-crossover study
por: Yen, Chieh-Li, et al.
Publicado: (2019)

The Efficiency of Intravenous Iron Therapy in Korean Inflammatory Bowel Disease Patients
por: Kim, Kyeong Ok
Publicado: (2016)

Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial
por: Sedighi, Omid, et al.
Publicado: (2013)

The impact of intravenous iron supplementation in elderly patients undergoing major surgery
por: Blum, Lea Valeska, et al.
Publicado: (2022)

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study
por: Peters, N. O., et al.
Publicado: (2017)

Effect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia
por: Karlsson, Torbjörn, et al.
Publicado: (2016)

Intravenous iron therapy for patients with heart failure: expanding body of evidence
por: Adlbrecht, Christopher
Publicado: (2019)

When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?
por: Rostoker, Guy
Publicado: (2018)

When is high-dose intravenous iron repletion needed? Assessing new treatment options
por: Gozzard, David
Publicado: (2011)

Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis
por: Yoshida, Shunsuke, et al.
Publicado: (2023)

Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial)
por: Anumas, Suthiya, et al.
Publicado: (2023)

A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKD
por: Greenwood, Sharlene A., et al.
Publicado: (2023)

S311: EFFICACY OF INTRAVENOUS IRON TREATMENT FOR CANCER PATIENT WITH ANEMIA, RANDOMIZED CONTROLLED STUDY
por: Ho Jang, Jun, et al.
Publicado: (2023)

Riding the Ferrous Wheel of Iron Supplementation in Pulmonary Arterial Hypertension
por: Krasinkiewicz, Jonathan M., et al.
Publicado: (2021)

Vascular calcification and left ventricular hypertrophy in hemodialysis patients: interrelationship and clinical impacts
por: Hwang, Hyeon Seok, et al.
Publicado: (2018)

Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2012)

Denosumab, an effective osteoporosis treatment option for men
por: Kong, Sung Hye
Publicado: (2022)

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients
por: Mudge, David W, et al.
Publicado: (2009)

Effect of Maintenance Intravenous Iron Treatment on Erythropoietin Dose in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial
por: Susantitaphong, Paweena, et al.
Publicado: (2020)

Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study
por: Deng, Yinghui, et al.
Publicado: (2017)

Association between Iron Status and Survival in Patients on Chronic Hemodialysis
por: Kang, Seok-Hui, et al.
Publicado: (2023)

Combination of Multiple Hemodialysis Modes: Better Treatment Options for Patients Under Maintenance Hemodialysis
por: Zhang, Zhi-Yong, et al.
Publicado: (2021)

Hepcidin-25, Mean Corpuscular Volume, and Ferritin as Predictors of Response to Oral Iron Supplementation in Hemodialysis Patients
por: Takasawa, Kazuya, et al.
Publicado: (2014)

Correction: Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
por: Kuo, Ko-Lin, et al.
Publicado: (2013)

Comparison of oral and intravenous Alfacalcidol in chronic hemodialysis patients
por: Lessard, Myriam, et al.
Publicado: (2014)

The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data
por: Pollak, Victor E, et al.
Publicado: (2009)

Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders
por: Takasawa, Kazuya, et al.
Publicado: (2018)

Evaluation of the Cost of a High-Dose Intravenous Iron Protocol in a Regional Hemodialysis Program: Research Letter
por: Papini, Adam, et al.
Publicado: (2021)

Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis Patients
por: Karaboyas, Angelo, et al.
Publicado: (2020)

High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients
por: Honda, Hirokazu, et al.
Publicado: (2017)

Intravenous iron supplementation in heart failure patients induces temporary endothelial dysfunction with release of endothelial microvesicles
por: Mause, Sebastian F., et al.
Publicado: (2023)

Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty
por: Shin, Kyun-Ho, et al.
Publicado: (2020)

What are the Options for Better Outcomes of Total Hip Arthroplasty?
por: Kim, Shin-Yoon
Publicado: (2010)

Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners
por: Chand, Deepa H., et al.
Publicado: (2009)

Geriatric assessment in elderly hemodialysis patients
por: Erken, Ertugrul
Publicado: (2019)

Intravenous iron isomaltoside versus oral iron supplementation for treatment of iron deficiency in pregnancy: protocol for a randomised, comparative, open-label trial
por: Markova, Veronika, et al.
Publicado: (2020)

Treatment Option for Aged, Multiparous Women With a Chronic Anal Fissure
por: Hwang, Yong Hee
Publicado: (2014)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0m398c3vjpgmpado999ec45o50